Research is making progress towards the goal of developing a flu vaccination that lasts longer, which might have a significant impact on public health.
One possible approach to creating a vaccine that protects against the flu for an extended period is to focus on a region of the hemagglutinin (HA) glycoprotein that is less likely to undergo mutations, according to research published in Science Translational Medicine.
After administering their vaccine to ferrets and mice, researchers discovered it provided superior protection compared to the standard method of vaccination. Additional study is necessary, but this test’s effectiveness provides direction for developing a flu vaccine with longer half-lives. Medical Offices of Manhattan internist Yoshua Quinones, MD, who is board certified, provided commentary on the study. Read the article.
